THE EFFECT OF APROTININ ON BLOOD PRODUCT REQUIREMENTS DURING ORTHOTOPIC LIVER-TRANSPLANTATION

被引：0
|
作者：
BECHSTEIN, WO
RIESS, H
NEUHAUS, P
HIMMELREICH, G
STEFFEN, R
SLAMA, KJ
ROSSAINT, R
BLUMHARDT, G
机构：
来源：
CLINICAL TRANSPLANTATION | 1991年 / 5卷 / 06期
关键词：
LIVER TRANSPLANTATION; BLOOD TRANSFUSION; APROTININ;
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
The effect of aprotinin, a protease inhibiting agent, on blood product requirements in liver transplantation was investigated in a prospective, open, non-randomized study. From September 1988 until January 1990, 60 consecutive liver transplantations were performed in 56 adult recipients. The first 10 patients (group I) were treated without aprotinin; for the next 50 transplantations (group II) aprotinin was applied in a total dose of 1.5-2.0 mio units i.v. intraoperatively. During primary transplants a mean of 9.7 +/- 5.5 units packed red blood cells (RBC) were substituted in group I vs. 7.5 +/- 4.6 units RBC in group II (n.s.). Fresh frozen plasma was substituted with 10.4 +/- 6.2 (group I) vs. 9.1 +/- 6.7 (group II) units (n.s.). Adverse effects of aprotinin were not observed. The trend towards decreased transfusion requirements and the observation of reduced fibrinolysis prompted us to continue routine use of aprotinin in liver transplantation.
引用
收藏
页码：422 / 426
页数：5
相关论文
共 50 条
  • [1] The effect of aprotinin on transfusion requirements in pediatric orthotopic liver transplantation
    Rentoul, TM
    Harrison, VL
    Shun, A
    PEDIATRIC TRANSPLANTATION, 2003, 7 (02) : 142 - 148
  • [2] IMPACT OF APROTININ ON BLOOD-TRANSFUSION REQUIREMENTS IN LIVER-TRANSPLANTATION
    SMITH, O
    HAZLEHURST, G
    BROZOVIC, B
    ROLLES, K
    BURROUGHS, A
    MALLETT, S
    DAWSON, K
    MEHTA, A
    TRANSFUSION MEDICINE, 1993, 3 (02) : 97 - 102
  • [3] IMPROVED HEMODYNAMIC STABILITY WITH ADMINISTRATION OF APROTININ DURING ORTHOTOPIC LIVER-TRANSPLANTATION
    MILROY, SJ
    COTTAM, S
    TAN, KC
    HILMI, I
    OYESOLA, B
    BRITISH JOURNAL OF ANAESTHESIA, 1995, 75 (06) : 747 - 751
  • [4] Aprotinin Versus Tranexamic Acid During Liver Transplantation: Impact on Blood Product Requirements and Survival
    Massicotte, Luc
    Denault, Andre Y.
    Beaulieu, Danielle
    Thibeault, Lynda
    Hevesi, Zoltan
    Roy, Andre
    TRANSPLANTATION, 2011, 91 (11) : 1273 - 1278
  • [5] Effect of aprotinin on blood loss and coagulation parameters in orthotopic liver transplantation
    Kratzer, MAA
    Azad, SC
    Groh, J
    Welte, M
    Haller, M
    Pratschke, E
    ANAESTHESIST, 1997, 46 (04): : 294 - 302
  • [6] Requirements for transfusion and postoperative outcomes in orthotopic liver transplantation:A meta-analysis on aprotinin
    Cun-Ming Liu
    World Journal of Gastroenterology, 2008, (09) : 1425 - 1429
  • [7] Requirements for transfusion and postoperative outcomes in orthotopic liver transplantation: A meta-analysis on aprotinin
    Liu, Cun-Ming
    Chen, Jing
    Wang, Xue-Hao
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (09) : 1425 - 1429
  • [8] Hemostasis and blood requirements in orthotopic liver transplantation with and without high-dose aprotinin
    Llamas, P
    Cabrera, R
    Gómez-Arnau, J
    Fernández, MN
    HAEMATOLOGICA, 1998, 83 (04) : 338 - 346
  • [9] THE INTRAOPERATIVE USE OF TRASYLOL (APROTININ) IN LIVER-TRANSPLANTATION
    MALLETT, SV
    COX, D
    BURROUGHS, AK
    ROLLES, K
    TRANSPLANT INTERNATIONAL, 1991, 4 (04) : 227 - 230
  • [10] BLOOD-CONCENTRATIONS OF DOPEXAMINE IN PATIENTS DURING AND AFTER ORTHOTOPIC LIVER-TRANSPLANTATION
    GRAY, PA
    JONES, T
    PARK, GR
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 37 (01) : 89 - 92
12345